基于代谢组学的功能性蛹虫草成分研究

对功能性蛹虫草、野生蛹虫草、柞蚕蛹虫草及冬虫夏草的代谢组学进行非靶向成分比较分析,并对功能性蛹虫草的常见生物活性成分进行定量分析。结果表明,功能性蛹虫草共检测出代谢产物成分2 213种,占成分总量的72.67%,其特有成分497种,与冬虫夏草、柞蚕蛹虫草和野生蛹虫草相比具有显著的成分优势。除目前已经报导的部分成分外,还含有丰富的特殊性代谢产物,如灵芝酸、茯苓新酸、人参皂苷、仙茅皂苷、苦玄参苷、黄芪皂苷、金铁锁环肽、王不留行环肽、甾醇、丹酚酸等。常规成分定量分析表明功能性蛹虫草子实体中虫草素和喷司他丁含量均较高,麦角甾醇、SOD酶、维生素E含量均显著高于对照组。大量药物活性物质在蛹虫草代谢产物成分体系中得到表达,对于揭示蛹虫草保健价值的物质基础具有重要意义。     

柞蚕蛹培养蛹虫草不同时间后的代谢组分析

为了解柞蚕蛹培养蛹虫草(简称柞蚕蛹虫草)不同时间后的代谢物变化规律,利用广泛靶向代谢组学技术,比较不同培养时期的柞蚕蛹虫草代谢产物成分,找出差异代谢物并进行代谢通路分析.在柞蚕蛹虫草的5个生长时期共检测到10类421种化合物,主要包括:氨基酸及其衍生物、核苷酸及其衍生物、萜类、酚酸、有机酸、糖及醇类、甾体、脂类、生物碱...     

柞蚕蛹虫草继代培育其活性物质变化规律

柞蚕蛹虫草中含有虫草素、腺苷、多糖等多种活性成分,具有提高免疫力、抗疲劳、保护心脑血管、抗癌等方面的作用,是冬虫夏草的良好替代品。以柞蚕蛹虫草的继代培育为基础,分别检测蛹虫草菌在不同传代次数时柞蚕蛹虫草子实体生长状态、蛹虫草中腺苷、虫草素、虫草多糖含量及蛹虫草菌菌丝、分生孢子中活性氧的分布。第1代蛹虫草菌接种后柞蚕蛹出现腐烂现象;第2、3代培育的子实体生长量、腺苷及虫草素含量均较高;第4代子实体生长量、腺苷及虫草素含量均出现大幅下降的现象。柞蚕蛹虫草中虫草多糖含量在传代过程中也逐渐降低,但降低幅度较腺苷和虫草素缓慢。第2代培育的柞蚕蛹虫草子实体生长状态优于第3代,故第2代蛹虫草菌更适合应用于批量生产。蛹虫草菌退化后含有活性氧的分生孢子比例增大,这可能是发生退化的表象之一。     

蛹虫草饲料添加剂的研究现状及展望

蛹虫草饲料添加剂包括蛹虫草子实体、蛹虫草培养残基、蛹虫草及其培养残基提取物、蛹虫草菌固液发酵产物、微生物发酵蛹虫草残基等产品.蛹虫草饲料添加剂含有粗蛋白、粗脂肪、氨基酸等营养成分,以及虫草素、腺苷、多糖等活性成分,在畜禽、反刍动物、水产品等动物养殖中的应用均获得较好的效果.对蛹虫草子实体、蛹虫草培养残基、蛹虫草及其培养...     

谷胱甘肽促进液体发酵体系中蛹虫草合成虫草素

虫草素是药用真菌蛹虫草Cordyceps militaris的主要活性成分,具有抗癌、抗肿瘤、抗病毒等多种生理活性.研究表明,氧化应激参与丝状真菌的次级代谢调控,然而在蛹虫草虫草素代谢中尚未见报道.本研究以蛹虫草深层液体发酵体系为研究对象,添加谷胱甘肽(glutathione,GSH)调节细胞氧化还原状态,考察其对虫草...     

人工培养蛹虫草

用柞蚕的活蛹 ,大米米饭培养基培养蛹虫草菌 ,控制好环境条件 ,严格操作环节 ,可培养出与天然蛹虫草形态相同的蛹虫草子座。用棉籽壳、玉米芯、葵花盘粉碎物培养蛹虫草菌 ,可以得到抑菌杀菌物质 ,成本低廉 ,可利用此法提取广谱抗菌物质。     

蛹虫草原基分化的差异蛋白质组学研究

蛹虫草子实体形成及发育的蛋白分子机制尚不清楚,本研究引入SWATH非标记定量蛋白质组学技术,对蛹虫草Cordyceps militaris 905菌株的菌丝体（mycelium,My）、原基（primordium,Po）、生长期子实体（developmental fruiting body,DF）和成熟期子实体（mature fruiting body,MF）进行了比较蛋白质组学分析。经搜库比对,从蛹虫草的My、Po、DF和MF中依次鉴定蛋白1 136个、1 090个、1 018个和997个（global FDR 1%）,经维恩分析后获得C. militaris 905蛹虫草表达蛋白1 578个。在此基础上,SWATH非标记技术定量蛋白1 109个。本研究获得了蛹虫草Po期与My期、DF期与Po期、MF期与DF期的差异表达蛋白,依次为115个、352个和104个,并对菌丝体分化形成原基的差异表达蛋白进行了重点解析。GO注释结果表明,Po期与My期差异表达蛋白以有机含氮类化合物代谢为主,其中AMP（活性成分虫草素合成的中间产物）从头生物合成途径富集最为显著。约1/5的差异表达蛋白参与氧化还原反应,还原酶活性的蛋白在原基中几乎都上调表达,而氧化功能的蛋白受到抑制,表明蛹虫草原基分化可能受到氧化应激的诱导。蛋白互作网络分析结果进一步表明,氧化还原反应与核苷类物质代谢相关联,可能通过影响AMP从头生物合成途径来调控虫草素的生物合成。对蛹虫草子实体系统的蛋白质组学研究和解析有利于揭示子实体形成的蛋白分子机制,为蛹虫草的基础和栽培研究提供了理论支撑。     

本期重点推介

正昆虫体内海藻糖含量及海藻糖酶活力变化与昆虫滞育和滞育的解除有密切关系。为了探讨柞蚕Antheraea pernyi蛹滞育过程中海藻糖酶基因的作用,沈阳农业大学生物科学技术学院王德意、王勇和秦利等利用RT-PCR技术从柞蚕蛹中克隆获得3个海藻糖酶基因,再分别采用半定量RT-PCR和qPCR方法检测了这些基因在柞蚕滞育和发育蛹不同组织中的表达谱及长光照(17L∶7D)处理蛹滞育解除过程中脂肪     

蛹虫草组学研究进展

作为虫草属的模式种,蛹虫草是目前虫草类真菌中研究和应用最为广泛的物种之一。随着基因组序列的公布,蛹虫草组学水平的研究近年来取得了明显的进展。本文从基因组、线粒体基因组、甲基化组、转录组、蛋白质组、代谢网络等角度对蛹虫草组学水平的研究现状进行综述,期望对进一步推动蛹虫草的深入研究提供帮助。     

虫草素产量不同的蛹虫草菌株代谢组差异

为探究虫草素高产和低产的两株蛹虫草菌代谢差异及其与虫草素代谢的关联性,本研究采用UPLC-QTOF-MS广泛靶向代谢组学技术和多元统计分析方法,结合相同蛹虫草菌不同发酵时间的菌丝体差异代谢物相对含量的变化情况,比较了两株蛹虫草菌相同发酵时间的菌丝体代谢差异.结果 表明:蛹虫草ClCC 14014菌株发酵第20和10天的...     

肠道菌群与高尿酸血症及痛风的相关性研究

高尿酸血症以及痛风的发病率持续升高,已经成为一个重大的公共卫生问题。肠道菌群的结构改变或失调可引起机体代谢紊乱,肠道微生态尤其与代谢性疾病的发生发展关系密切。目前研究发现高尿酸血症、痛风患者存在肠道菌群失调,降尿酸治疗后肠道菌群可发生相应改变,并且益生菌制剂具有降尿酸作用。本文概述高尿酸血症及痛风患者的肠道菌群特点,从高嘌呤及高果糖饮食对肠道菌群的影响、肠道参与嘌呤和尿酸的代谢、代谢性内毒素血症以及痛风相关炎症因子等方面探讨肠道菌群与高尿酸血症及痛风的关系,并展望肠道菌群可能成为未来诊治高尿酸血症以及痛风的一种新方法。     

Metabonomic studies on potential plasma biomarkers in rats exposed to ionizing radiation and the protective effects of Hong Shan Capsule

An ultra performance liquid chromatography coupled to mass spectrometry-based metabonomic approach, combined with pattern recognition methods including PCA, PLS-DA, RF and heatmap, has been developed to characterize the global serum metabolic profile associated with ionizing radiation (IR). As the VIP-value threshold cutoff of the metabolites was set to 2, metabolites above this threshold were filtered out as potential target biomarkers. Nineteen distinct potential biomarkers in rat plasma were identified. To further elucidate the pathophysiology of IR, related metabolic pathways have been studied. It was found that IR was closely related to disturbed fatty acid metabolism, taurine and hypotaurine metabolism, sphingolipid metabolism, purine metabolism, pyrimidine metabolism, phospholipid catabolism, tryptophan metabolism, phenylalanine metabolism, and bile acid metabolism. With the presented metabonomic method, we systematically analyzed the protective effects of Traditional Chinese Medicine Hong Shan Capsule (HSC). The results demonstrated that HSC administration could provide satisfactory effects on IR through partially regulating the perturbed metabolic pathways.     

A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF/HDMS

Chronic kidney disease (CKD) is an important public health problem. Ergone has been proved to prevent the progression of CKD. UPLC-QTOF/HDMS was employed for metabolic profiling of adenine-induced CKD and to investigate the nephroprotective effects of ergone. Pharmacology parameters including blood biochemistry, histopathological evaluation and Western blot analysis were performed concurrently. The UPLC-MS data were analyzed by partial least squares-discriminate analysis, correlation analysis, heatmap analysis and mapped to KEGG pathways. Blood and serum biochemistry were observed to be significantly different in the CKD group than in the control group. In conjunction with biochemistry, histopathology and protein expression results, identified metabolites indicated perturbations in fatty acid metabolism, purine metabolism and amino acid metabolism as changes associated with adenine-induced CKD and the interventions of ergone. Upregulated expression of TGF-β1, ED-1, CTGF, bFGF and collagen I was observed in the CKD group. However, downregulated expression of these proteins was observed after oral administration of ergone. These results suggest that expression changes in these proteins had implications for fatty acid metabolism, purine metabolism and amino acid metabolism in the development of CKD and that ergone treatment could delay the development of CKD by normalizing or blocking abnormal changes in biomarker metabolites and protein expression in the CKD group.     

Effects of dopamine D2 receptor antagonists on retinal pigment epithelial/choroid complex metabolism in form-deprived myopic guinea pigs

The retinal pigment epithelial (RPE)/choroid complex regulates myopia development, but the precise pathogenesis of myopia remains unclear. We aimed to investigate the changes in RPE/choroid complex metabolism in a form deprivation myopia model after dopamine D2 receptor (D2R) modulation. Guinea pigs were randomly divided into normal (NC), form deprivation myopia (FDM), and FDM treated with dopamine D2R antagonist groups. Differential metabolites were screened using SIMCA-P software and MetaboAnalyst metabolomics analysis tool. Functions of differential metabolites were analyzed using KEGG enrichment pathways. Relative to the NC group, 38 differential metabolites were identified, comprising 29 increased metabolites (including nicotinic acid, cytosine, and glutamate) and 9 decreased metabolites, of which proline exhibited the largest decrease. Pathway analysis revealed regulation of arginine/proline and aspartate/glutamate metabolism. Intravitreal D2R antagonist injection increased proline concentrations and activated arginine/proline and purine metabolism pathways. In sum, D2R antagonists alleviated the myopia trend of refractive biological parameters in form deprivation myopic guinea pigs, suggesting the involvement of dopamine D2R signaling in myopia pathogenesis. The RPE/choroid may provide glutamate to the retina by activating proline metabolism via metabolic coupling with the retina. Dopamine D2R antagonism may modulate proline/arginine metabolic pathways in the RPE/choroid and regulate metabolism, information presentation, and myopia.     

降血尿酸益生菌株的筛选和降血尿酸机理的探索

【背景】高尿酸血症是人体内血尿酸含量显著高于正常水平的代谢性疾病,利用益生菌降解食物中外源性嘌呤类成分成为治疗高尿酸血症的新方法。【目的】筛选具有降低血尿酸作用的益生菌,并探索其作用机制。【方法】利用HPLC从多株实验菌株中筛选降解核苷酸(腺苷酸、鸟苷酸)、核苷(腺苷、鸟苷)、嘌呤(黄嘌呤、次黄嘌呤、鸟嘌呤)、尿酸能力最强的益生菌。首次利用质谱定性与定量检测菌株降解核苷与核苷酸过程中代谢物的变化,结合菌株对高尿酸血症模型大鼠血尿酸水平的影响,初步探索其降低血尿酸的机理。【结果】首次筛选出具有较强降解核苷酸与核苷能力的干酪乳杆菌ZM15(CGMCC No.13980),高尿酸血症模型大鼠验证其具有降低血尿酸的作用。结果显示菌株ZM15在胞内降解核苷酸、核苷后,胞内、外均测到鸟嘌呤、黄嘌呤、次黄嘌呤,且胞内3种嘌呤含量显著高于正常菌体内含量(P0.01),尿酸和尿囊素在胞内、外均未发现。【结论】干酪乳杆菌ZM15具有较强的降解核苷酸、核苷的能力,推测其主要通过与肠道上皮细胞竞争吸收核苷酸与核苷,从而对高尿酸血症模型大鼠具有降血尿酸作用。     

肠道菌群失调与高尿酸血症关系的研究进展

高尿酸血症（hyperuricemia,HUA）是一种涉及肝、肾、肠等多个器官的代谢性疾病,因尿酸代谢异常而引起代谢障碍。尿酸在肝脏和肾脏中的代谢途径目前已经被阐明,但在肠道内的代谢途径尚未完全清晰。肠道菌群在人体肠道中定植,与宿主存在互惠共生的关系,在宿主的代谢和免疫调节中起着至关重要的作用。肠道菌群结构的变化可能引起代谢紊乱,肠道菌群参与嘌呤代谢酶的合成和炎症因子的释放,与HUA的发生发展密切相关。肠道菌群作为探讨HUA发病机制的切入点,已成为新的研究热点。本综述主要阐述HUA与肠道菌群之间的关系,探讨肠道菌群抗HUA的机制,如肠道菌群促进嘌呤和尿酸分解代谢,影响尿酸排泄,以及HUA引起的肠道炎症反应等,以期为通过调节肠道菌群来治疗HUA提供一定的依据。

     

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

The purine analogue, allopurinol, has been in clinical use for more than 30 years as an inhibitor of xanthine oxidase (XO) in the treatment of hyperuricemia and gout. As consequences of structural similarities to purine compounds, however, allopurinol, its major active product, oxypurinol, and their respective metabolites inhibit other enzymes involved in purine and pyrimidine metabolism. Febuxostat (TEI-6720, TMX-67) is a potent, non-purine inhibitor of XO, currently under clinical evaluation for the treatment of hyperuricemia and gout. In this study, we investigated the effects of febuxostat on several enzymes in purine and pyrimidine metabolism and characterized the mechanism of febuxostat inhibition of XO activity. Febuxostat displayed potent mixed-type inhibition of the activity of purified bovine milk XO, with Ki and Ki' values of 0.6 and 3.1 nM respectively, indicating inhibition of both the oxidized and reduced forms of XO. In contrast, at concentrations up to 100 muM, febuxostat had no significant effects on the activities of the following enzymes of purine and pyrimidine metabolism: guanine deaminase, hypoxanthine-guanine phosphoribosyltransferase, purine nucleoside phosphorylase, orotate phosphoribosyltransferase and orotidine-5'-monophosphate decarboxylase. These results demonstrate that febuxostat is a potent non-purine, selective inhibitor of XO, and could be useful for the treatment of hyperuricemia and gout.